Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Nisha Andany, Janet M. Raboud, Sharon Walmsley, Christina Diong, Sean B. Rourke, Sergio Rueda, Anita Rachlis, Wendy Wobeser, Rodger D. MacArthur, Louise Binder, Ron Rosenes & Mona R. Loutfy. (2011) Ethnicity and Gender Differences in Lipodystrophy of HIV-Positive Individuals Taking Antiretroviral Therapy in Ontario, Canada. HIV Clinical Trials 12:2, pages 89-103.
Read now
Read now
Articles from other publishers (32)
Christin G. Hong, Elizabeth Florida, Haiou Li, Philip M. Parel, Nehal N. Mehta & Alexander V. Sorokin. (2023) Oxidized low-density lipoprotein associates with cardiovascular disease by a vicious cycle of atherosclerosis and inflammation: A systematic review and meta-analysis. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Anthony Jaworowski, Anna C. Hearps, Thomas A. Angelovich & Jennifer F. Hoy. (2019) How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy. Frontiers in Immunology 10.
Crossref
Crossref
Suman Srinivasa, Kathleen V. Fitch, Martin Torriani, Markella V. Zanni, Christopher Defilippi, Robert Christenson, Patrick Maehler, Sara E. Looby, Janet Lo & Steven K. Grinspoon. (2019) Relationship of visceral and subcutaneous adipose depots to markers of arterial injury and inflammation among individuals with HIV. AIDS 33:2, pages 229-236.
Crossref
Crossref
S Berger, G Ceccarini, G Scabia, I Barone, C Pelosini, F Ferrari, S Magno, A Dattilo, L Chiovato, P Vitti, F Santini & M Maffei. (2017) Lipodystrophy and obesity are associated with decreased number of T cells with regulatory function and pro-inflammatory macrophage phenotype. International Journal of Obesity 41:11, pages 1676-1684.
Crossref
Crossref
Suelen J. Souza, Aline A. Petrilli, Andrea M. Teixeira, Patricia M. Pontilho, Antonio A. Carioca, Liania A. Luzia, José M. Souza, Nágila R. Damasceno, Aluisio A. Segurado & Patricia H. Rondó. (2017) Effect of chocolate and mate tea on the lipid profile of individuals with HIV/AIDS on antiretroviral therapy: A clinical trial. Nutrition 43-44, pages 61-68.
Crossref
Crossref
Theodoros Kelesidis, Thuy Tien T Tran, Todd T Brown, Carlee Moser, Heather J Ribaudo, Michael P Dube, Otto O Yang, Grace A McComsey, James H Stein & Judith S Currier. (2016) Changes in Plasma Levels of Oxidized Lipoproteins and Lipoprotein Subfractions with Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy and Associations with Common Carotid Artery Intima-Media Thickness: ACTG 5260s. Antiviral Therapy 22:2, pages 113-126.
Crossref
Crossref
V Estrada, S Monge, MD Gómez‐Garre, P Sobrino, M Masiá, J Berenguer, J Portilla, C Viladés, E Martínez & JR Blanco. (2016)
Relationship between plasma bilirubin level and oxidative stress markers in
HIV
‐infected patients on atazanavir‐
vs
. efavirenz‐based antiretroviral therapy
. HIV Medicine 17:9, pages 653-661.
Crossref
Crossref
Kenneth R. Feingold & Carl Grunfeld. (2016) Effect of inflammation on HDL structure and function. Current Opinion in Lipidology 27:5, pages 521-530.
Crossref
Crossref
Nicholas T. Funderburg & Nehal N. Mehta. (2016) Lipid Abnormalities and Inflammation in HIV Inflection. Current HIV/AIDS Reports 13:4, pages 218-225.
Crossref
Crossref
Alison Castley, Leah Williams, Ian James, George Guelfi, Cassandra Berry & David Nolan. (2016) Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors. PLOS ONE 11:6, pages e0158169.
Crossref
Crossref
Eric Nou, Michael T. Lu, Sara E. Looby, Kathleen V. Fitch, Elli A. Kim, Hang Lee, Udo Hoffmann, Steven K. Grinspoon & Janet Lo. (2016) Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV. AIDS 30:4, pages 583-590.
Crossref
Crossref
Corrilynn O. Hileman, Randi Turner, Nicholas T. Funderburg, Richard D. Semba & Grace A. McComsey. (2016) Changes in oxidized lipids drive the improvement in monocyte activation and vascular disease after statin therapy in HIV. AIDS 30:1, pages 65-73.
Crossref
Crossref
David A. Zidar, Steven Juchnowski, Brian Ferrari, Brian Clagett, Heather A. Pilch-Cooper, Shawn Rose, Benigno Rodriguez, Grace A. McComsey, Scott F. Sieg, Nehal N. Mehta, Michael M. Lederman & Nicholas T. Funderburg. (2015) Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation. JAIDS Journal of Acquired Immune Deficiency Syndromes 69:2, pages 154-160.
Crossref
Crossref
Lynn PulliamCyrus CalosingBing SunCarl GrunfeldHans Rempel. (2014) Monocyte Activation from Interferon-α in HIV Infection Increases Acetylated LDL Uptake and ROS Production. Journal of Interferon & Cytokine Research 34:10, pages 822-828.
Crossref
Crossref
Eleonora Olivetta, Valentina Tirelli, Chiara Chiozzini, Beatrice Scazzocchio, Ignazio Romano, Claudia Arenaccio & Massimo Sanchez. (2014) HIV-1 Nef Impairs Key Functional Activities in Human Macrophages through CD36 Downregulation. PLoS ONE 9:4, pages e93699.
Crossref
Crossref
Newton Guerreiro da Silva Júnior, Erick Nelo Pedreira, Fabrício Mesquita Tuji, Luiza Verônica Warmling & Karem L. Ortega. (2014) Prevalence of calcified carotid artery atheromas in panoramic radiographs of HIV-positive patients undergoing antiretroviral treatment: a retrospective study. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 117:1, pages 67-74.
Crossref
Crossref
Davide Gibellini, Marco Borderi, Alberto Clò, Silvia Morini, Anna Miserocchi, Isabella Bon, Cristina Ponti & Maria Carla Re. (2013) HIV-related mechanisms in atherosclerosis and cardiovascular diseases. Journal of Cardiovascular Medicine 14:11, pages 780-790.
Crossref
Crossref
Sabrina Uda, Stefano Spolitu, Fabrizio Angius, Maria Collu, Simonetta Accossu, Sebastiano Banni, Elisabetta Murru, Francesca Sanna & Barbara Batetta. (2013) Role of HDL in cholesteryl ester metabolism of lipopolysaccharide-activated P388D1 macrophages. Journal of Lipid Research 54:11, pages 3158-3169.
Crossref
Crossref
Ronald Vargas Orellana, Henrique Andrade Rodrigues Fonseca, Andrea Moreira Monteiro, Karem Lopes Ortega, Maria Helena Gallottini, Magnus Gidlund & Andrea Mantesso Pobocik. (2013) Association of autoantibodies anti-OxLDL and markers of inflammation with stage of HIV infection. International Journal of Cardiology 168:2, pages 1610-1612.
Crossref
Crossref
Ciro José Brito, Edmar Lacerda Mendes, Aparecido Pimentel Ferreira, Sérgio Oliveira De Paula, Otávio de Tolêdo Nóbrega & Cláudio Córdova. (2013) Impacto do treinamento resistido na força e hipertrofia muscular em HIV-soropositivos. Motriz: Revista de Educação Física 19:2, pages 313-324.
Crossref
Crossref
Markella V. Zanni & Steven K. Grinspoon. (2012) HIV-Specific Immune Dysregulation and Atherosclerosis. Current HIV/AIDS Reports 9:3, pages 200-205.
Crossref
Crossref
Shan Yu, Siu Ling Wong, Chi Wai Lau, Yu Huang & Cheuk-Man Yu. (2011) Oxidized LDL at low concentration promotes in-vitro angiogenesis and activates nitric oxide synthase through PI3K/Akt/eNOS pathway in human coronary artery endothelial cells. Biochemical and Biophysical Research Communications 407:1, pages 44-48.
Crossref
Crossref
Tochi Okwuosa. 2011. Hyperlipidemia in Primary Care. Hyperlipidemia in Primary Care
181
204
.
Anna Maisa, Clare Westhorpe, Julian Elliott, Anthony Jaworowski, Anna C Hearps, Anthony M Dart, Jennifer Hoy & Suzanne M Crowe. (2010) Premature onset of cardiovascular disease in HIV-infected individuals: the drugs and the virus. HIV Therapy 4:6, pages 675-692.
Crossref
Crossref
Sangeeta Mehendale, Han Aung, Chong-Zhi Wang, Robin Tong, Adela Foo, Jing-Tian Xie & Chun-Su Yuan. (2007)
Scutellaria baicalensis
and a constituent flavonoid, baicalein, attenuate ritonavir-induced gastrointestinal side-effects
. Journal of Pharmacy and Pharmacology 59:11, pages 1567-1572.
Crossref
Crossref
F. Boccara, J. Capeau, M. Caron, C. Vigouroux & A. Cohen. (2009) VIH, antirétroviraux, dyslipidémie et risque cardiovasculaire. Médecine des Maladies Métaboliques 3:1, pages 59-64.
Crossref
Crossref
C. Vigouroux & J. Capeau. (2009) Lipodystrophies et troubles métaboliques associés à l'infection par le virus de l'immunodéficience humaine (VIH) et à ses traitements. EMC - Endocrinologie - Nutrition 6:3, pages 1-10.
Crossref
Crossref
C. Vigouroux, M. Caron, J.-P. Bastard, F. Boccara & J. Capeau. (2008) Les lipodystrophies et les troubles métaboliques associés à l’infection par le VIH et à son traitement : données actuelles. Médecine des Maladies Métaboliques 2:6, pages 573-578.
Crossref
Crossref
Carl Grunfeld, Donald P. Kotler, Donna K. Arnett, Julian M. Falutz, Steven M. Haffner, Paul Hruz, Henry Masur, James B. Meigs, Kathleen Mulligan, Peter Reiss & Katherine Samaras. (2008) Contribution of Metabolic and Anthropometric Abnormalities to Cardiovascular Disease Risk Factors. Circulation 118:2.
Crossref
Crossref
Nasser E. Mikhail. (2008) Lipid Abnormalities in Patients Infected With HumanImmunodeficiency Virus. Endocrine Practice 14:4, pages 492-500.
Crossref
Crossref
Adelina Munteanu & Jean-Marc Zingg. (2007) Cellular, molecular and clinical aspects of vitamin E on atherosclerosis prevention. Molecular Aspects of Medicine 28:5-6, pages 538-590.
Crossref
Crossref
Emma Hammond & David Nolan. (2007) Adipose tissue inflammation and altered adipokine and cytokine production in antiretroviral therapy-associated lipodystrophy. Current Opinion in HIV and AIDS 2:4, pages 274-281.
Crossref
Crossref